Skip to content
★ Sign in to follow
VD

Veeral Desai

Directeur de la Stratégie et du Développement
Total declarations
41
Company
1
▲ Purchases (1 ops.)
—
▼ Sales (17 ops.)
€30.2M

Latest filing published 17 Apr 2024 for agilon health, inc..

Insider track record

Disclosed buys
1
Disclosed sells
17

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Veeral Desai: trading record in brief

This profile gathers the share dealings of Veeral Desai in Agilon Health, Inc., where the filings describe the role as senior executive. In total, 41 filings cover trades dated from 14 April 2021 to 15 April 2024.

Both buying and selling appear: 1 purchase, against 17 sales worth €30.2M. The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 8 share grants and 15 option exercises. In 2024 alone, the filings show 1 purchase and no sales.

The newest entry dates from 17 April 2024: a share grant of €22k, in Agilon Health, Inc. The most recent open-market purchase was published on 18 March 2024, 966 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Veeral Desai

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total
  • ◆
    Chief Strategy & Dev. OfficerExecutivesAgilon Health, Inc.
    0SEC
    196,189 shares0Common StockSEC:0001628280-24-016653:0
  • ▲
    Chief Strategy & Dev. OfficerExecutivesAgilon Health, Inc.
    0SEC
    11,956 sharesCommon StockSEC:0001628280-24-011773:0
    Canonical exit: 12 Jun 2024 (T+90)
  • ◇
    Chief Strategy & Dev. OfficerExecutivesAgilon Health, Inc.
    13,500 USD25SEC
    4,500 shares@ US$3.000.9% of flowCommon StockSEC:0001209191-23-028800:0
  • ◇
    Chief Strategy & Dev. OfficerExecutivesAgilon Health, Inc.
    15,000 USD25SEC
    5,000 shares@ US$3.001.0% of flowCommon StockSEC:0001209191-23-025112:0
  • ◆
    Chief Strategy & Dev. OfficerExecutivesAgilon Health, Inc.
    0SEC
    26,353 shares0Common StockSEC:0001209191-23-024666:0
  • ◇
    Chief Strategy & Dev. OfficerExecutivesAgilon Health, Inc.
    68,130 USD25SEC
    22,710 shares@ US$3.004.7% of flowCommon StockSEC:0001209191-23-021209:0
  • ◇
    Chief Strategy & Dev. OfficerExecutivesAgilon Health, Inc.
    180,000 USD26SEC
    60,000 shares@ US$3.0012.7% of flowCommon StockSEC:0001209191-23-019722:0
  • ◆
    Chief Strategy & Dev. OfficerExecutivesAgilon Health, Inc.
    34,190 USD25SEC
    1,482 shares@ US$23.072.4% of flowCommon StockSEC:0001209191-22-051528:0
  • ◇
    Chief Strategy & Dev. OfficerExecutivesAgilon Health, Inc.
    79,768 USD26SEC
    79,768 shares@ US$1.005.8% of flowCommon StockSEC:0001209191-22-043105:0
  • ◇
    Chief Strategy & Dev. OfficerExecutivesAgilon Health, Inc.
    319,071 USD27SEC
    319,071 shares@ US$1.0023.4% of flowCommon StockSEC:0001209191-22-041801:0
  • ◇
    Chief Strategy & Dev. OfficerExecutivesAgilon Health, Inc.
    106,357 USD19SEC
    106,357 shares@ US$1.000.0073% mcap15.4% of flowCommon StockSEC:0001209191-22-039598:0
  • ◇
    Chief Strategy & Dev. OfficerExecutivesAgilon Health, Inc.
    79,568 USD12SEC
    79,568 shares@ US$1.005.9% of flowCommon StockSEC:0001209191-22-025550:0
  • ◇
    Chief Strategy & Dev. OfficerExecutivesAgilon Health, Inc.
    106,357 USD12SEC
    106,357 shares@ US$1.008.0% of flowCommon StockSEC:0001209191-22-025160:0
  • ◆
    Chief Strategy & Dev. OfficerExecutivesAgilon Health, Inc.
    0SEC
    16,255 shares0Common StockSEC:0001209191-22-025009:0
  • ◇
    Chief Strategy & Dev. OfficerExecutivesAgilon Health, Inc.
    197,291 USD12SEC
    197,291 shares@ US$1.0014.5% of flowCommon StockSEC:0001209191-22-020015:0
  • ◇
    Chief Strategy & Dev. OfficerExecutivesAgilon Health, Inc.
    121,001 USD12SEC
    121,001 shares@ US$1.008.3% of flowCommon StockSEC:0001209191-21-056200:0

16 of 16 declarations